Published in J Virol on May 01, 1991
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol (1993) 5.41
NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol (1993) 4.60
Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol (1993) 4.57
Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J Virol (1997) 4.35
Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol (2005) 4.31
A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A (1993) 4.30
Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol (1994) 3.51
Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol (1991) 3.41
Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol (1994) 3.35
Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev (1993) 3.33
Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci U S A (1991) 2.97
Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol (1995) 2.76
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol (1994) 2.64
Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol (1993) 2.56
Completion of Kunjin virus RNA sequence and recovery of an infectious RNA transcribed from stably cloned full-length cDNA. J Virol (1994) 2.43
The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J Virol (1999) 2.34
Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol (1992) 2.33
Molecular targets for flavivirus drug discovery. Antiviral Res (2008) 2.32
Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. J Virol (1993) 2.25
NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J Virol (1994) 2.11
Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol (1993) 2.06
Bovine viral diarrhea virus NS3 serine proteinase: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication. J Virol (1997) 2.00
Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proc Natl Acad Sci U S A (1993) 1.99
cis- and trans-acting elements in flavivirus RNA replication. J Virol (2000) 1.91
Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci U S A (1992) 1.89
Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci U S A (1991) 1.87
Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res (2009) 1.87
Crystal structure of the NS3 protease-helicase from dengue virus. J Virol (2007) 1.84
Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum. J Virol (1995) 1.79
An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol (1995) 1.78
Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity. J Virol (2001) 1.73
Yellow fever: a reemerging threat. Clin Lab Med (2010) 1.69
Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J Virol (2005) 1.65
Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci (2007) 1.63
Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5. J Virol (1992) 1.59
Structural proteomics of dengue virus. Curr Opin Microbiol (2008) 1.57
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3. J Virol (2000) 1.56
Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen. Antimicrob Agents Chemother (2008) 1.54
Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem J (2006) 1.49
Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J Virol (2001) 1.49
Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage. J Virol (1995) 1.49
Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication. J Biol Chem (2011) 1.45
Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study. J Virol (1994) 1.42
Enzymatic characterization of hepatitis C virus NS3/4A complexes expressed in mammalian cells by using the herpes simplex virus amplicon system. J Virol (1996) 1.38
Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol (1996) 1.32
Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus. J Virol (1992) 1.31
Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J Virol (1996) 1.31
Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol (2009) 1.29
De novo synthesis of negative-strand RNA by Dengue virus RNA-dependent RNA polymerase in vitro: nucleotide, primer, and template parameters. J Virol (2003) 1.28
Flavivirus enzyme-substrate interactions studied with chimeric proteinases: identification of an intragenic locus important for substrate recognition. J Virol (1991) 1.27
Posttranslational signal peptidase cleavage at the flavivirus C-prM junction in vitro. J Virol (1995) 1.27
Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol (2011) 1.25
Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. J Virol (1999) 1.25
Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus. J Virol (1996) 1.22
Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease. J Virol (1995) 1.22
The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J Virol (1995) 1.21
A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan. Genet Vaccines Ther (2012) 1.21
Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J Virol (2004) 1.19
Successful propagation of flavivirus infectious cDNAs by a novel method to reduce the cryptic bacterial promoter activity of virus genomes. J Virol (2011) 1.16
Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly. Bioinformation (2013) 1.12
A three-dimensional comparison of tick-borne flavivirus infection in mammalian and tick cell lines. PLoS One (2012) 1.11
Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J Virol (2000) 1.10
Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob Agents Chemother (2010) 1.09
Structure-based discovery of dengue virus protease inhibitors. Antiviral Res (2009) 1.07
Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes. J Virol (1993) 1.07
Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J Virol (1999) 1.07
Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses. Biochem J (2007) 1.07
Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components. J Virol (1997) 1.06
NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J Virol (1995) 1.06
Characterisation of divergent flavivirus NS3 and NS5 protein sequences detected in Rhipicephalus microplus ticks from Brazil. Mem Inst Oswaldo Cruz (2013) 1.04
Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis. J Virol (2007) 1.02
The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication. J Biol Chem (2014) 1.01
Mutagenesis of the NS3 protease of dengue virus type 2. J Virol (1998) 0.99
Novel ATP-independent RNA annealing activity of the dengue virus NS3 helicase. PLoS One (2012) 0.95
Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family. J Virol (2009) 0.94
Focus on flaviviruses: current and future drug targets. Future Med Chem (2009) 0.94
Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease. Biochemistry (2008) 0.92
Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides. Biochem J (2006) 0.92
NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus. Genet Mol Biol (2010) 0.90
Characterization of dengue virus NS4A and NS4B protein interaction. J Virol (2015) 0.90
Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease. Antiviral Res (2012) 0.89
Effects of detergents on the West Nile virus protease activity. Bioorg Med Chem (2009) 0.88
Design of new competitive dengue NS2B/NS3 protease inhibitors-a computational approach. Int J Mol Sci (2011) 0.88
Autocatalytic cleavage within classical swine fever virus NS3 leads to a functional separation of protease and helicase. J Virol (2013) 0.87
A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature (2016) 0.87
Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1. BMC Infect Dis (2012) 0.87
Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines. PLoS One (2011) 0.86
The role of viral persistence in flavivirus biology. Pathog Dis (2014) 0.86
Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors. Antiviral Res (2011) 0.86
Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells. J Biomed Biotechnol (2012) 0.86
Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Antivir Chem Chemother (2011) 0.86
Novel flaviviruses from mosquitoes: mosquito-specific evolutionary lineages within the phylogenetic group of mosquito-borne flaviviruses. Virology (2014) 0.85
Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines. Virology (2011) 0.85
Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays. J Virol (2008) 0.84
Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in vitro. Antiviral Res (2012) 0.84
Anthracene-based inhibitors of dengue virus NS2B-NS3 protease. Antiviral Res (2010) 0.83
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol (1985) 13.99
Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science (1985) 8.54
Viral proteinases. Annu Rev Biochem (1988) 6.76
Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology (1988) 4.78
Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology (1986) 4.34
N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res (1989) 4.27
Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A (1990) 4.12
Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specified proteins. J Gen Virol (1988) 4.09
Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology (1987) 3.96
Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology (1986) 3.85
Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology (1990) 3.58
Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. Virology (1989) 3.55
The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. Virology (1987) 3.51
In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J Virol (1990) 3.50
Flaviviridae. Intervirology (1985) 3.06
Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol (1989) 3.03
Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis. Virology (1989) 2.87
Primary structure of the West Nile flavivirus genome region coding for all nonstructural proteins. Virology (1986) 2.75
Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. Virology (1990) 2.50
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Acidotropic amines inhibit proteolytic processing of flavivirus prM protein. Virology (1990) 2.34
Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full-length genome. Virology (1988) 2.22
The flaviviruses (group B arboviruses): a cross-neutralization study. J Gen Virol (1974) 2.18
Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene (1989) 2.15
Gene mapping and positive identification of the non-structural proteins NS2A, NS2B, NS3, NS4B and NS5 of the flavivirus Kunjin and their cleavage sites. J Gen Virol (1988) 2.12
Sequence analysis of the viral core protein and the membrane-associated proteins V1 and NV2 of the flavivirus West Nile virus and of the genome sequence for these proteins. Virology (1985) 2.07
Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins. J Virol (1989) 2.07
Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses. Virology (1978) 2.06
Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol (1990) 2.05
In vitro processing of dengue virus structural proteins: cleavage of the pre-membrane protein. J Virol (1989) 2.02
Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. J Mol Biol (1986) 1.96
Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology (1989) 1.76
Tick-borne encephalitis virus genome. The nucleotide sequence coding for virion structural proteins. FEBS Lett (1986) 1.74
Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1. J Virol (1990) 1.73
Sequence analysis of the membrane protein V3 of the flavivirus West Nile virus and of its gene. Virology (1985) 1.72
Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity. J Virol (1987) 1.67
Methylation status of intracellular dengue type 2 40 S RNA. Virology (1979) 1.63
Nucleotide sequence of the genome and complete amino acid sequence of the polyprotein of tick-borne encephalitis virus. Virology (1990) 1.62
Carboxy-terminal analysis of nine proteins specified by the flavivirus Kunjin: evidence that only the intracellular core protein is truncated. J Gen Virol (1989) 1.50
Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology (1987) 1.39
Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses. Virology (1986) 1.31
Characterization of protease cleavage sites involved in the formation of the envelope glycoprotein and three non-structural proteins of dengue virus type 2, New Guinea C strain. J Gen Virol (1987) 1.26
Partial nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue virus type 2, New Guinea C and PUO-218 strains. J Gen Virol (1988) 1.25
Definition of the carboxy termini of the three glycoproteins specified by dengue virus type 2. Virology (1989) 1.20
Amino-terminal amino acid sequences of structural proteins of three flaviviruses. Virology (1985) 1.20
Positive identification of NS4A, the last of the hypothetical nonstructural proteins of flaviviruses. Virology (1989) 1.14
Identification of Saint Louis encephalitis virus mRNA. J Virol (1978) 1.11
Molecular cloning and complete nucleotide sequence of the genome of Japanese encephalitis virus Beijing-1 strain. Virus Genes (1988) 1.02
Translation of tick-borne encephalitis virus (flavivirus) genome in vitro: synthesis of two structural polypeptides. Virology (1981) 1.01
In vitro synthesis of Japanese encephalitis virus (JEV) RNA: membrane and nuclear fractions of JEV-infected cells possess high levels of virus-specific RNA polymerase activity. Virus Res (1989) 0.98
Togavirus RNA: reversible effect of urea on genomes and absence of subgenomic viral RNA in Kunjin virus-infected cells. Arch Virol (1977) 0.96
Sequence of the 3' half of the Murray Valley encephalitis virus genome and mapping of the nonstructural proteins NS1, NS3, and NS5. Virus Genes (1990) 0.91
Amino acid compositions and amino-terminal sequences of the structural proteins of a flavivirus, European Tick-Borne Encephalitis virus. Virology (1983) 0.90
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Deletion mutants of simian virus 40 generated by enzymatic excision of DNA segments from the viral genome. J Mol Biol (1974) 5.47
Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci U S A (1971) 5.23
Identification of simian virus 40 protein A. J Virol (1977) 4.93
Evolution of organic aerosols in the atmosphere. Science (2009) 4.82
A map of temperature-sensitive mutants of simian virus 40. Virology (1975) 4.77
Mapping temperature-sensitive mutants of simian virus 40: rescue of mutants by fragments of viral DNA. Virology (1974) 4.30
Mapping the spliced and unspliced late lytic SV40 RNAs. Cell (1978) 4.25
Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell (1980) 4.18
Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction. J Bacteriol (1971) 3.93
Splicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40. Proc Natl Acad Sci U S A (1979) 3.89
Cloning full-length dengue type 4 viral DNA sequences: analysis of genes coding for structural proteins. Virology (1986) 3.85
The nucleotide sequence of dengue type 4 virus: analysis of genes coding for nonstructural proteins. Virology (1987) 3.51
Structure of an inducibly methylatable nucleotide sequence in 23S ribosomal ribonucleic acid from erythromycin-resistant Staphylococcus aureus. Biochemistry (1973) 3.19
A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol (1996) 3.18
Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol (1989) 3.03
Processing and expression of early SV40 mRNA: a role for RNA conformation in splicing. Cell (1979) 2.80
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Am J Trop Med Hyg (2001) 2.67
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Alteration of 23 S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus. J Mol Biol (1973) 2.51
Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol (1992) 2.33
Deletion mutants of simian virus 40 defective in biosynthesis of late viral mRNA. Proc Natl Acad Sci U S A (1979) 2.19
Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol (1993) 2.06
Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis. J Virol (1990) 2.05
Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome. Virology (1995) 1.95
Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains. Virology (1981) 1.94
Cell surface expression of the influenza virus hemagglutinin requires the hydrophobic carboxy-terminal sequences. Cell (1982) 1.92
Nonviral oligonucleotides at the 5' terminus of cytoplasmic influenza viral mRNA deduced from cloned complete genomic sequences. Cell (1980) 1.91
Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci U S A (1992) 1.89
Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1). Virology (1982) 1.87
Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci U S A (1991) 1.87
Genetic determinants of dengue type 4 virus neurovirulence for mice. J Virol (1993) 1.78
Functional expression in primate cells of cloned DNA coding for the hemagglutinin surface glycoprotein of influenza virus. Proc Natl Acad Sci U S A (1981) 1.75
Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Virology (1996) 1.74
Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1. J Virol (1990) 1.73
Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. J Virol (1987) 1.72
Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice. J Virol (1993) 1.72
Dengue virus, a flavivirus, propagates in human bone marrow progenitors and hematopoietic cell lines. Blood (1989) 1.69
The B/C gene of simian virus 40. Virology (1976) 1.67
Mapping the genes of simian virus 40. Cold Spring Harb Symp Quant Biol (1975) 1.66
Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40. Cell (1978) 1.61
Structure of beta-ketoacyl-[acyl carrier protein] reductase from Escherichia coli: negative cooperativity and its structural basis. Biochemistry (2001) 1.57
Sequence of the influenza A/Udorn/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA. Virology (1982) 1.56
Dengue virus-specific cross-reactive CD8+ human cytotoxic T lymphocytes. J Virol (1989) 1.55
Cloning DNA sequences from influenza viral RNA segments. Proc Natl Acad Sci U S A (1980) 1.54
Hepatitis B virus transcript produced by RNA splicing. J Virol (1989) 1.52
The clinical observation of difficult laryngoscopy and difficult intubation in infants with cleft lip and palate. Paediatr Anaesth (2006) 1.48
Mechanistic diversity and regulation of Type II fatty acid synthesis. Biochem Soc Trans (2002) 1.46
Expression of unspliced NS1 mRNA, spliced NS2 mRNA, and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology (1984) 1.46
Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme. Biochemistry (1994) 1.43
Non-specific termination of simian virus 40 DNA replication. J Mol Biol (1975) 1.41
Chromatic sensitive epilepsy: a variant of photosensitive epilepsy. Ann Neurol (1999) 1.40
Orotracheal to nasotracheal tube exchange in children. Minerva Anestesiol (2010) 1.39
Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. Biochemistry (1995) 1.36
Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J Virol (1998) 1.34
Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol (1995) 1.32
Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus. J Virol (1992) 1.31
Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg (2000) 1.29
Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J Virol (1988) 1.29
High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1. J Virol (2000) 1.29
Dengue virus premembrane and membrane proteins elicit a protective immune response. Virology (1991) 1.29
Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge. J Virol (1996) 1.28
Glycosylation and surface expression of the influenza virus neuraminidase requires the N-terminal hydrophobic region. Mol Cell Biol (1984) 1.26
Electron microscope study of the base sequence homology between simian virus 40 and human papovavirus BK. J Virol (1978) 1.23
Distinct expression and shared activities of members of the hedgehog gene family of Xenopus laevis. Development (1995) 1.22
Enantiopure N-acyldihydropyridones as synthetic intermediates: asymmetric synthesis of benzomorphans. Org Lett (1999) 1.21
Dissecting Wnt signalling pathways and Wnt-sensitive developmental processes through transient misexpression analyses in embryos of Xenopus laevis. Dev Suppl (1993) 1.20
Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. J Virol (1989) 1.20
Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice. J Virol (1991) 1.17
Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J Virol (1995) 1.13
Specification of the anteroposterior neural axis through synergistic interaction of the Wnt signaling cascade with noggin and follistatin. Dev Biol (1995) 1.12
The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur J Cancer (2002) 1.11
Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases. J Gen Virol (1995) 1.11
Anticancer and antiradical scavenging activity of Ageratum conyzoides L. (Asteraceae). Pharmacogn Mag (2010) 1.11
Biomechanical evaluation of posterior and anterior lumbar interbody fusion techniques. J Spinal Disord (1998) 1.10
Steady-state vibration somatosensory evoked potentials: physiological characteristics and tuning function. Clin Neurophysiol (1999) 1.10
Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes. J Virol (1993) 1.07
Defects in functional expression of an influenza virus hemagglutinin lacking the signal peptide sequences. Proc Natl Acad Sci U S A (1983) 1.06
Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition. Biochemistry (1995) 1.03
The influenza virus nucleoprotein synthesized from cloned DNA in a simian virus 40 vector is detected in the nucleus. J Virol (1983) 1.00
Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein. Arch Virol (2007) 1.00
Preliminary results of Thymosin-a1 versus interferon-alpha-treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J Gastroenterol (2001) 0.99
Mapping simian virus 40 mutants by marker rescue. Methods Enzymol (1980) 0.98
Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. J Neural Transm Suppl (2007) 0.97
Occurrence of temperature-sensitive influenza A viruses in nature. J Virol (1982) 0.97
A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. Proc Natl Acad Sci U S A (1996) 0.96
Functional similarity between the early antigens of simian virus 40 and human papovavirus BK. J Virol (1979) 0.94
Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones. J Virol (1994) 0.94
NMR study of a Lewis(X) pentasaccharide derivative: solution structure and interaction with cations. Carbohydr Res (1999) 0.94
Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection. Antimicrob Agents Chemother (1996) 0.93
Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein. Am J Trop Med Hyg (1993) 0.92
Influenza virus hemagglutinin containing an altered hydrophobic carboxy terminus accumulates intracellularly. J Virol (1984) 0.92
A general approach to construct double deletion mutants of SV40. Virology (1979) 0.90